All News #Library
Rare Diseases
LBL-024 Clinical Data in Advanced EP-NEC Revealed at 2025 ASCO
31 May 2025 //
PR NEWSWIRE
FDA Grants Orphan Drug Status to LBL-024 for Neuroendocrine Cancer
22 Nov 2024 //
PR NEWSWIRE
Leads Biolabs Gets FDA Orphan Drug Status for LBL-034 in Myeloma
06 Nov 2024 //
PR NEWSWIRE

Market Place
Sourcing Support